{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:18:34Z","timestamp":1760404714069},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T00:00:00Z","timestamp":1497312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00210-017-1386-z","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T11:46:58Z","timestamp":1497354418000},"page":"883-892","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice"],"prefix":"10.1007","volume":"390","author":[{"given":"Olajide S.","family":"Annafi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oritoke M.","family":"Aluko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony T.","family":"Eduviere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osarume","family":"Omorogbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Umukoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"key":"1386_CR1","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/0006-2952(82)90106-X","volume":"34","author":"V Adam-Vizi","year":"1982","unstructured":"Adam-Vizi V, Seregi A (1982) Receptor independent stimulatory effect of noradrenaline on Na+\/K+-ATPase in rat brain homogenate. Role of lipid peroxidation Biochem Pharmacol 34:2231\u20132236","journal-title":"Role of lipid peroxidation Biochem Pharmacol"},{"key":"1386_CR2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.pnpbp.2004.06.019","volume":"28","author":"A Becker","year":"2004","unstructured":"Becker A, Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Progress in Neuropsychopharmacol Biological Psychiatr 28:1267\u20131277","journal-title":"Progress in Neuropsychopharmacol Biological Psychiatr"},{"issue":"3","key":"1386_CR3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","volume":"35","author":"BKY Bitanihirwe","year":"2011","unstructured":"Bitanihirwe BKY, Woo TW (2011) Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 35(3):878\u2013893","journal-title":"Neurosci Biobehav Rev"},{"key":"1386_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000118305","volume":"19","author":"M Bourin","year":"1986","unstructured":"Bourin M, Poisson L, Larousse C (1986) Piracetam interaction with neuroleptics in psychopharmacological tests. Neuropsychobiology 19:93\u201396","journal-title":"Neuropsychobiology"},{"key":"1386_CR5","doi-asserted-by":"crossref","unstructured":"Bowles DJ (1990) Defense-related proteins in higher plant. Ann Rev Biochemistr 59:873\u2013907","DOI":"10.1146\/annurev.bi.59.070190.004301"},{"key":"1386_CR6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1021694307672","volume":"26","author":"RE Brown","year":"1999","unstructured":"Brown RE, Corey SC, Mooren AK (1999) Differences in measures of exploration and fear in MHC congenic C578\/61 and B6-H-2K mice. Behaviour Genetic 26:263\u2013271","journal-title":"Behaviour Genetic"},{"issue":"5","key":"1386_CR7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.neubiorev.2008.03.012","volume":"32","author":"V Buben\u00edkov\u00e1-Valesov\u00e1","year":"2008","unstructured":"Buben\u00edkov\u00e1-Valesov\u00e1 V, Hor\u00e1cek J, Vrajov\u00e1 M, H\u00f6schl C (2008) Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 32(5):1014\u20131023","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"1386_CR8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jat.768","volume":"21","author":"E Candelario-Jalil","year":"2001","unstructured":"Candelario-Jalil E, Al-Dalain SM, Castillo R, Mart\u00ednez G, Le\u00f3n OS (2001) Selective vulnerability to kainate-induced oxidative damage in different rat brain regions. J Appl Toxicol 21(5):403\u2013407","journal-title":"J Appl Toxicol"},{"key":"1386_CR9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbadis.2006.01.008","volume":"1762","author":"V Casadesus","year":"2006","unstructured":"Casadesus V, Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, Smith MA (2006) Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochimica Biophysica Acta 1762:447\u2013452","journal-title":"Biochimica Biophysica Acta"},{"key":"1386_CR10","doi-asserted-by":"crossref","unstructured":"Cesari IM, Carvalho E, Rodrigues MF, Mendon\u00e7a BS, Am\u00f4edo ND, Rumjanek FD (2014) Methyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosis. Int J Cell Biol 2014:1\u201325","DOI":"10.1155\/2014\/572097"},{"key":"1386_CR11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neuropharm.2012.05.041","volume":"63","author":"M Chatterjee","year":"2012","unstructured":"Chatterjee M, Rajkumar V, Surajit G, Gautam P (2012) Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Neuropharmacology 63:1161\u20131171","journal-title":"Neuropharmacology"},{"key":"1386_CR12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0028-3908(78)90090-4","volume":"17","author":"B Costall","year":"1978","unstructured":"Costall B, Hui SCG, Naylor RJ (1978) Correlation between multitest and single test catalepsy assessment. Neuropharmacology 17:761\u2013764","journal-title":"Neuropharmacology"},{"key":"1386_CR13","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"KL Davis","year":"1991","unstructured":"Davis KL, Kahn RS, Grant KO, Davidson M (1991) Dopamine in schizophrenia: a new review and conceptualization. Am J Psychiat 148:1474\u20131486","journal-title":"Am J Psychiat"},{"key":"1386_CR14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00008877-199208000-00003","volume":"3","author":"GR Dawson","year":"1992","unstructured":"Dawson GR, Heyes CM, Iversen SD (1992) Pharmacological mechanisms and animal models of cognition. Behav Pharmacol 3:286\u2013297","journal-title":"Behav Pharmacol"},{"key":"1386_CR15","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2174\/092986709788803060","volume":"16","author":"OM Dean","year":"2009","unstructured":"Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M (2009) A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem 16:2965\u20132976","journal-title":"Curr Med Chem"},{"key":"1386_CR16","unstructured":"Deanna MB, Sheffield JM (2014) Cognitive impairments in psychotic disorders: common mechanisms and measurement. World Psychiat 13(3):224\u2013232"},{"key":"1386_CR17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4236\/aad.2014.32009","volume":"3","author":"XH Deng","year":"2014","unstructured":"Deng XH, Li M, Ai W, He L, Lu D, Patrylo PR, Cai H, Luo X, Li ZX, Yan X-X (2014) Lipolysaccharide-induced neuroinflammation is associated with Alzheimer-like amyloidogenic axonal pathology and dendritic degeneration in rats. Advances Alzheimer\u2019s Disease 3:78\u201393","journal-title":"Advances Alzheimer\u2019s Disease"},{"issue":"8","key":"1386_CR18","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/jclp.20612","volume":"65","author":"ML Draper","year":"2009","unstructured":"Draper ML, Stutes DS, Maples NJ, Velligan DL (2009) Cognitive adaptation training for outpatients with schizophrenia. J Clin Psychol 65(8):842\u2013853","journal-title":"J Clin Psychol"},{"key":"1386_CR19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2015.04.007","volume":"132","author":"AT Eduviere","year":"2015","unstructured":"Eduviere AT, Umukoro S, Aderibigbe AO, Ajayi AM, Adewole FA (2015) Methyl jasmonate enhances memory performance through inhibition of oxidative stress and acetylcholinesteras activity in mice. Life Sci 132:20\u201326","journal-title":"Life Sci"},{"key":"1386_CR20","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s11064-016-2050-6","volume":"41","author":"AT Eduviere","year":"2016","unstructured":"Eduviere AT, Umukoro S, Adeoluwa OA, Omogbiya IA, Aluko OM (2016) Possible methyl mechanisms involved in attenuation of lipopolysaccharide-induced memory deficits by jasmonate in mice. Neurochem Res 41:3239\u20133249","journal-title":"Neurochem Res"},{"key":"1386_CR21","doi-asserted-by":"crossref","unstructured":"Fukuda K (2014) 5-HTP hypothesis of schizophrenia. Med Hypotheses 82:20\u201323","DOI":"10.1016\/j.mehy.2013.10.026"},{"key":"1386_CR22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0013-7006(06)76151-6","volume":"32","author":"C Fendri","year":"2006","unstructured":"Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L (2006) Oxidative stress involvement in schizophrenia pathophysiology: a review. Enceephale 32:244\u2013252","journal-title":"Enceephale"},{"key":"1386_CR23","doi-asserted-by":"crossref","unstructured":"Geyer MA, Vollenweider FX (2008) Serotonin research: contributions to understanding psychoses. Trends in Pharmacological Sci 29:445\u2013453","DOI":"10.1016\/j.tips.2008.06.006"},{"key":"1386_CR24","doi-asserted-by":"crossref","unstructured":"Gornall AG, Bardawill CJ, David MM (1949) Determination of serum protein by means of biuret reaction. J Biol Chem 177:751\u2013766","DOI":"10.1016\/S0021-9258(18)57021-6"},{"key":"1386_CR25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","volume":"97","author":"B Halliwell","year":"2006","unstructured":"Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochemistr 97:1634\u20131658","journal-title":"J Neurochemistr"},{"key":"1386_CR26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","volume":"120","author":"DC Hoffman","year":"1995","unstructured":"Hoffman DC, Donovan H (1995) Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacol (Berlin) 120:128\u2013133","journal-title":"Psychopharmacol (Berlin)"},{"key":"1386_CR27","unstructured":"Hossain SY, Aoshima H, Corda H, Kiso Y (2004) Fragrances in oolong that enhance the response of GABAA receptors. Biosci Biochnol Biochem 68:1242\u20131248"},{"issue":"1","key":"1386_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1476-5381.1976.tb06959.x","volume":"56","author":"AM Johnson","year":"1976","unstructured":"Johnson AM, Loew DM, Vigouret JM (1976) Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and l-dopa. Br J Pharmacol 56(1):59\u201368","journal-title":"Br J Pharmacol"},{"key":"1386_CR29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.31887\/DCNS.2010.12.3\/jkane","volume":"12","author":"JM Kane","year":"2010","unstructured":"Kane JM, Correll CU (2010) Pharmacologic treatment of schizophrenia. Dialogues Clin Neurosci 12:345\u2013357","journal-title":"Dialogues Clin Neurosci"},{"key":"1386_CR30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neuroscience.2004.03.039","volume":"126","author":"G Keilhoff","year":"2004","unstructured":"Keilhoff G, Becker A, Grecksch G, Wolf G, Bernstein HG (2004) Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 126:591\u2013598","journal-title":"Neuroscience"},{"key":"1386_CR31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2007-1000680","volume":"59","author":"F Kukla","year":"1999","unstructured":"Kukla F, Gold R (1999) Negative schizophrenic symptoms and their detection. Fortschr Neurol Psychiatr 59:60\u201366","journal-title":"Fortschr Neurol Psychiatr"},{"key":"1386_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00421-005-1402-8","volume":"95","author":"K Kuroda","year":"2005","unstructured":"Kuroda K, Inoue N, Ito Y, Kubota K, Sugimoto A, Kakuda T, Fushiki T (2005) Sedative effects of the jasmine tea odor and (R)-(\u2212)-linalool, one of its major odor components on autonomic nerve activity and mood states. Eur J Appl Physiol 95:107\u2013114","journal-title":"Eur J Appl Physiol"},{"key":"1386_CR33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/npp.2010.156","volume":"36","author":"TA Lesh","year":"2011","unstructured":"Lesh TA, Niendam TA, Minzenberg MJ, Carter CS (2011) Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology 36:316\u2013338","journal-title":"Neuropsychopharmacology"},{"issue":"7985","key":"1386_CR34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(76)91816-X","volume":"2","author":"S Lipper","year":"1976","unstructured":"Lipper S (1976) Psychosis in patient on bromocriptine and levodopa with carbidopa. Lancet 2(7985):571\u2013572","journal-title":"Lancet"},{"issue":"1","key":"1386_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","volume":"19","author":"SP Mahadik","year":"1996","unstructured":"Mahadik SP, Mukherjee S (1996) Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophrenia Res 19(1):1\u201317","journal-title":"Schizophrenia Res"},{"key":"1386_CR36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","volume":"17","author":"AK Malhotra","year":"1997","unstructured":"Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997) Ketamine- induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic- free schizophrenics. Neuropsychopharmacology 17:141\u2013150","journal-title":"Neuropsychopharmacology"},{"issue":"suppl 2","key":"1386_CR37","first-page":"3","volume":"6","author":"DD Miller","year":"2004","unstructured":"Miller DD (2004) Atypical antipsychotics: sleep, sedation, and efficacy. Prim Care Companion J Clin Psychiatry 6(suppl 2):3\u20137","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"1386_CR38","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"HP Misra","year":"1972","unstructured":"Misra HP, Fridovich I (1972) The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170\u20133175","journal-title":"J Biol Chem"},{"key":"1386_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67\u201378","journal-title":"Biochim Biophys Acta"},{"key":"1386_CR40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1192\/apt.12.4.239","volume":"12","author":"PE Mullen","year":"2006","unstructured":"Mullen PE (2006) Schizophrenia and violence: from correlations to preventive strategies. Adv Psychiat Treat 12:239\u2013248","journal-title":"Adv Psychiat Treat"},{"key":"1386_CR41","doi-asserted-by":"crossref","unstructured":"Ray WA, Chung CP, Murray KT, Hall K, Stein CM (2009) Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360:225\u201335","DOI":"10.1056\/NEJMoa0806994"},{"key":"1386_CR42","first-page":"18e25","volume":"19","author":"F Sams-Dodd","year":"1998","unstructured":"Sams-Dodd F (1998) Effects of continuous D-amphetamine and phencyclidineadministration on social behaviour, stereotyped behaviour, and locomotoractivity in rats. Neuropsychopharmacology 19:18e25","journal-title":"Neuropsychopharmacology"},{"key":"1386_CR43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-3223(85)90062-9","volume":"20","author":"S Shukla","year":"1985","unstructured":"Shukla S, Turner WJ, Newman G (1985) Bromocriptine-related psychosis and treatment. Biological Psychiatr 20:326\u2013328","journal-title":"Biological Psychiatr"},{"key":"1386_CR44","first-page":"389","volume":"147","author":"KA Sinha","year":"1971","unstructured":"Sinha KA (1971) Colorimetric assay of catalase. Anal Biochem 147:389\u2013394","journal-title":"Anal Biochem"},{"key":"1386_CR45","doi-asserted-by":"crossref","unstructured":"Umukoro S, Eduviere AT (2017) Methyl jasmonate attenuates memory dysfunction and decreases brain levels of biomarkers of neuroinflammation induced by lipopolysaccharide in mice. Brain Res Bull 131:133\u2013141.","DOI":"10.1016\/j.brainresbull.2017.04.002"},{"key":"1386_CR46","doi-asserted-by":"crossref","unstructured":"Umukoro S, Alabi AO, Aladeokin AC (2011) Antidepressant activity of methyl jasmonate, a plant stress hormone in mice. Pharmacol, Biochemist & Behav 98:8\u201311","DOI":"10.1016\/j.pbb.2010.12.001"},{"issue":"2","key":"1386_CR47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pbb.2011.12.015","volume":"101","author":"S Umukoro","year":"2012","unstructured":"Umukoro S, Eduviere AT, Aladeokin AC (2012) Anti-aggressive activity of methyl jasmonate and the probable mechanism of its action in mice. Pharmacol, Biochem & Behav 101(2):271\u2013277","journal-title":"Pharmacol, Biochem & Behav"},{"key":"1386_CR48","doi-asserted-by":"crossref","unstructured":"Umukoro S, Aluko OM, Eduviere AT and Owoeye O (2016) Evaluation of adaptogenic-like property of methyl jasmonate in mice exposed to unpredictable chronic mild stress. Brain Res Bull 121:105\u2013114","DOI":"10.1016\/j.brainresbull.2015.11.016"},{"key":"1386_CR49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7","author":"B Uttara","year":"2009","unstructured":"Uttara B, Singh AW, Zamboni P, Mahajan RT (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 7:65\u201374","journal-title":"Curr Neuropharmacol"},{"key":"1386_CR50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11427-010-0013-8","volume":"53","author":"M Zhang","year":"2010","unstructured":"Zhang M, Zhao Z, He L, Wan C (2010) A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci 53:112\u20131124","journal-title":"Sci China Life Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-017-1386-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1386-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1386-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:18:50Z","timestamp":1659111530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-017-1386-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1007\/s00210-017-1386-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,13]]}}}